ESRRA and colonic neoplasm: Knocking down ERRα in HCT-116p53+/+ (p53 wild-type), DLD-1, or HCT-15 (missense or GOF p53 mutants) colon cancer cell lines reduced the expression of the p53 protein, independent of p53 status (Fig. 2a).